# Tissue K+ in Primary Hyperaldosteronism

> **NCT04251780** · — · COMPLETED · sponsor: **University of Erlangen-Nürnberg Medical School** · enrollment: 21 (actual)

## Conditions studied

- Primary Hyperaldosteronism
- Electrolyte Disturbance

## Interventions

- **PROCEDURE:** Surgical Treatment of Primary Aldosteronism
- **DRUG:** Drug treatment of Primary Aldosteronism

## Key facts

- **NCT ID:** NCT04251780
- **Lead sponsor:** University of Erlangen-Nürnberg Medical School
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2024-04-24
- **Final completion:** 2024-04-24
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04251780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04251780, "Tissue K+ in Primary Hyperaldosteronism". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT04251780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*